McNealey Jennifer Isacoff 4
4 · CONDUIT PHARMACEUTICALS INC. · Filed May 15, 2024
Insider Transaction Report
Form 4
McNealey Jennifer Isacoff
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2024-05-13$5.51/sh−65,000$358,150→ 0 totalExercise: $5.51Exp: 2033-11-30→ Common Stock (65,000 underlying)
Footnotes (2)
- [F1]Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
- [F2]The stock options were granted with a ten-year term and vest 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.